Demonstration of skin fluorescence following exposure to doxorubicin.
D000970:Antineoplastic Agents / Q000032:analysis; D004317:Doxorubicin / Q000032:analysis*; D004347:Drug Interactions; D005453:Fluorescence; D006235:Hand Disinfection; D006801:Humans; D009741:Nursing Staff, Hospital; D009784:Occupational Diseases / Q000517:prevention & control; D012867:Skin / Q000032:analysis*
D000970:Antineoplastic Agents; D004317:Doxorubicin